Transcranial magnetic stimulation (TMS) for major depression: A multisite, naturalistic, observational study of acute treatment outcomes in clinical practice

Depression and Anxiety

Volumn 29, Issue 7, 2012, Pages 587-596

  Carpenter, Linda L ^a   Janicak, Philip G ^b   Aaronson, Scott T ^c   Boyadjis, Terrence ^d   Brock, David G ^e   Cook, Ian A ^f   Dunner, David L ^g   Lanocha, Karl ^h   Solvason, H Brent ⁱ   Demitrack, Mark A ^e  

^a BUTLER HOSPITAL   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c SHEPPARD PRATT HEALTH SYSTEM   (United States)

^d Private Practice Plymouth Meeting   (United States)

^e Neuronetics   (United States)

^f UCLA MEDICAL CENTER   (United States)

^g Center for Anxiety and Depression   (United States)

^h TMS Center of New England   (United States)

ⁱ STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

clinical trial; depression; observational study; transcranial magnetic stimulation

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; SERTRALINE;

ADULT; ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL PRACTICE; FEMALE; GRAND MAL EPILEPSY; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; OBSERVATIONAL STUDY; PATIENT SATISFACTION; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; SYMPTOM; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; COHORT STUDIES; DEPRESSIVE DISORDER, MAJOR; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; FEMALE; HUMANS; MALE; MIDDLE AGED; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

EID: 84863436099     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.21969     Document Type: Article

References (34)

1. World Health Organization. (2008) The Global Burden of Disease, 2004 Update. Geneva, Switzerland: WHO Press. Available at:. Retrieved 28 December, 2009.
2. Kessler R, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003; 289 (23): 3095-3105. (Pubitemid 37432885)
3. Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006; 163: 1905-1917. (Pubitemid 44807782)
4. Janicak PG, O'Reardon JP, Sampson SM, et al. Transcranial magnetic stimulation (TMS) in the treatment of major depression: a comprehensive summary of safety experience from acute and extended exposure and during reintroduction treatment. J Clin Psychiatry 2008; 69 (2): 222-232. (Pubitemid 351469265)
5. Guse B, Falkai P, Wobrock T,. Cognitive effects of high-frequency repetitive transcranial magnetic stimulation: a systematic review. J Neural Transm 2010; 117: 105-122.
6. Aarre TF, Johansen JB, Kjonniksen I, et al. Efficacy of repetitive transcranial magnetic stimulation in depression: a review of the evidence. Nord J Psychiatry 2003; 57: 227-232. (Pubitemid 36805996)
7. Allan CL, Herrmann LL, Ebmeier KP,. Transcranial magnetic stimulation in the management of mood disorders. Neuropsychobiology 2011; 64: 163-169.
8. Burt T, Lisanby SH, Sackeim HA., Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis. Int J Neuropsychopharmacol 2002; 5: 73-103. (Pubitemid 34241070)
9. Couturier J,. Efficacy of rapid-rate repetitive transcranial magnetic stimulation in the treatment of depression: a systematic review and meta-analysis. J Psychiatry Neurosci 2005; 30 (2): 83-90. (Pubitemid 40769298)
10. Gross M, Nakamura L, et al. Has repetitive transcranial magnetic stimulation (rTMS) treatment for depression improved? A systematic review and meta-analysis comparing the recent vs. the earlier rTMS studies. Acta Psychiat Scand 2007; 116: 165-173. (Pubitemid 47106664)
11. Herrmann L, Ebmeier K,. Factors modifying the efficacy of transcranial magnetic stimulation in the treatment of depression: a review. J Clin Psychiatry 2006; 67: 1870-1876. (Pubitemid 46048184)
12. Holtzheimer PE, et al. A meta-analysis of repetitive transcranial magnetic stimulation in the treatment of depression. Psychopharmacol Bulletin 2001; 35: 149-169.
13. Kozel FA, George MS,. Meta-analysis of left prefrontal repetitive transcranial magnetic stimulation to treat depression. J Psychiatric Prac 2002; 8: 270-275.
14. Lam RW, Chan P, Wilkins-Ho M, et al. Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis. Canad J Psychiatry 2008; 53 (9): 621-631.
15. Loo C, Mitchell P,. A review of the efficacy of transcranial magnetic stimulation (TMS) treatment for depression, and current and future strategies to optimize efficacy. J Aff Disorders 2005; 88: 255-267. (Pubitemid 41447523)
16. Martin JLR, Barbanoj MJ, Schlaepfer TE, et al. Transcranial magnetic stimulation for treating depression (review). Cochrane Library 2003;(4)
17. McNamara B, Ray JL, Arthurs OJ, et al. Transcranial magnetic stimulation for depression and other psychiatric disorders. Psychol Med 2001; 31: 1141-1146. (Pubitemid 32975879)
18. Schutter DJLG,. Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: a meta-analysis. Psychol Medicine 2009; 39: 65-75.
19. Slotema CW, Blom JD, Hoek HW, Sommer IEC,. Should we expand the toolbox of psychiatric treatment methods to include repetitive transcranial magnetic stimulation (rTMS)? A Meta-analysis of the efficacy of rTMS in psychiatric disorders. J Clin Psychiatry 2010; 71 (7): 873-884.
20. Sackeim HA,. The definition and meaning of treatment-resistant depression. J Clin Psychiatry 2001; 16: 10-17.
21. Bandelow B, Baldwin DS, Dolberg OT, Andersen HF, Stein DJ,. What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder. J Clin Psychiatry 2006; 67: 1428-1434. (Pubitemid 44583391)
22. Katzelnick DJ, Duffy FF, Chung H, Regier DA, Rae DS, Trivedi MH,. Depression outcomes in psychiatric clinical practice: using a self-rated measure of depression severity. Psychiatric Services 2011; 62 (8): 929-935.
23. Kornstein SG, Schneider RK,. Clinical features of treatment-resistant depression. J Clin Psychiatry 2001; 62 (Suppl 16): 18-25.
24. Rush AJ, Wisniewski SR, Warden D, et al. Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features. Arch Gen Psychiatry 2008; 65 (8): 870-881.
25. Berlanga C, Heinze G, Torres M, Apiquian R, Caballero A,. Personality and clinical predictors of recurrence of depression. Psychiatric Services 1999; 50 (3): 376-380. (Pubitemid 29122567)
26. O'Reardon JP, Solvason HB, Janicak PG, et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multi-site randomized controlled trial. Biol Psychiatry 2007; 62: 1208-1216. (Pubitemid 350060890)
27. Avery DH, Isenberg KE, Sampson SM, et al. TMS in the acute treatment of major depression: clinical response in an open-label extension trial. J Clin Psychiatry 2008; 69 (3): 441-451. (Pubitemid 351549398)
28. Demitrack MA, Thase ME,. Clinical significance of transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant depression: synthesis of recent data. Psychopharmacol Bulletin 2009; 42 (2): 5-38.
29. George MS, Lisanby SH, Avery D, et al. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder a sham-controlled randomized trial. Arch Gen Psychiatry 2010; 67 (5): 507-516.
30. McDonald WM, Durkalski V, Ball ER, et al. Improving the antidepressant efficacy of transcranial magnetic stimulation: maximizing the number of stimulations and treatment location in treatment-resistant depression. Depress Anxiety 2011; 28 (11): 973-980.
31. Wisniewski SR, Rush AJ, Nierenberg AA, et al. Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report. Am J Psychiatry 2009; 166: 599-607.
32. Hadley D, Anderson BS, Borckardt JJ, et al. Safety, tolerability, and effectiveness of high doses of adjunctive daily left prefrontal repetitive transcranial magnetic stimulation for treatment-resistant depression in a clinical setting J ECT 2011; 27 (1): 18-25.
33. Holtzheimer PE 3rd, McDonald WM, Mufti M, et al. Accelerated repetitive transcranial magnetic stimulation for treatment-resistant depression. Depress Anxiety 2010; 27 (10): 960-963.
34. Fitzgerald PB, Benitez J, de Castella A, Daskalakis ZJ, Brown TL, Kulkarni J,. A randomized, controlled trial of sequential bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression. Am J Psychiatry 2006; 163 (1): 88-94. (Pubitemid 43050108)